STAGE IIB PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIB PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIB PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart-Safe prostate cancer treatment? new study compares two drugs
Disease control Recruiting nowThis study compares two hormone therapies, Orgovyx and Eligard, used alongside radiation for prostate cancer. The goal is to see which one is less harmful to the heart. About 70 men with intermediate-risk prostate cancer will take one of the drugs for 6 months and undergo heart t…
Matched conditions: STAGE IIB PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:35 UTC
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation therapy (SBRT) works as well as a slightly longer radiation approach (hypofractionated radiotherapy) for men whose prostate cancer has returned or spread to a few spots after surgery. About 118 participants will receive o…
Matched conditions: STAGE IIB PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:30 UTC